Zealand Pharma (ZLDPF), a leader in peptide-based medicines, has announced the appointment of Utpal Singh as their new Chief Scientific Officer. Singh will be pivotal in steering the company's discovery research and translational sciences agendas.
With extensive experience in pharmaceutical development, Utpal Singh is set to enhance Zealand Pharma's innovation capabilities. Prior to this role, Singh contributed significantly as the Senior Vice President of Small Molecule Discovery at Eli Lilly and Company (LLY, Financial), bringing valuable expertise and leadership to his new position.
